Friday, 31 October 2014
Last updated 9 hours ago
Jul 25 2012 | 11:00am ET
A top healthcare hedge fund has gotten nearly big enough: OrbiMed Advisors will close its flagship hedge fund to new investment, possibly as soon as this quarter.
The firm's Caduceus Capital has some $1.8 billion in assets under management, having added $300 million in the second quarter thanks to strong performance and inflows. But the fund will shut out the latter when it reaches $2 billion, Hedge Fund Alert reports.
OrbiMed's popularity is no surprise: Caduceus is up 20% this year and has returned an average of 19% a year since its launch in 1993. What's more, the firm has never gated redemptions or moved any assets into side pockets.
OrbiMed runs a total of $6.2 billion, primarily in long-only and private equity funds.
Sep 22 2014 | 4:15pm ET
"I tell people that everybody likes good news and so if you have good performance that’s wonderful,” explains Mike McKitish of Peddie School's endowment, “but it’s the people that want to talk about the bad news or where they drifted and how they came back and how they stayed to their discipline…” that he wants to hear from. Read more…
Traders form habits quickly. Understanding these and their effects can better equip us to decipher actual market moves.